193 related articles for article (PubMed ID: 32822803)
21. Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome.
Pielop JA; Brownell I; Duvic M
Int J Dermatol; 2003 Feb; 42(2):116-22. PubMed ID: 12708999
[TBL] [Abstract][Full Text] [Related]
22. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
23. Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population.
Sherman S; Kremer N; Dalal A; Solomon-Cohen E; Berkovich E; Noyman Y; Ben-Lassan M; Levi A; Pavlovsky L; Prag Naveh H; Hodak E; Amitay-Laish I
Acta Derm Venereol; 2020 Dec; 100(19):adv00346. PubMed ID: 33241425
[TBL] [Abstract][Full Text] [Related]
24. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous lymphomas: single center experience of dermatology and hematology clinics.
Payzin B; Ogretmen Z; Cidem Yildirim A; Ozturk Durur S; Sentekin S
J BUON; 2014; 19(1):171-7. PubMed ID: 24659660
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides and Sézary syndrome in Japan. Clinicopathologic study of 107 autopsy cases.
Arai E; Katayama I; Ishihara K
Pathol Res Pract; 1991 May; 187(4):451-7. PubMed ID: 1876527
[TBL] [Abstract][Full Text] [Related]
27. Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study.
AbuHilal M; Walsh S; Shear N
J Cutan Med Surg; 2017; 21(6):507-512. PubMed ID: 28614957
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous malignant melanoma in association with mycosis fungoides.
Evans AV; Scarisbrick JJ; Child FJ; Acland KM; Whittaker SJ; Russell-Jones R
J Am Acad Dermatol; 2004 May; 50(5):701-5. PubMed ID: 15097953
[TBL] [Abstract][Full Text] [Related]
29. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
Lens MB; Newton-Bishop JA
Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
[TBL] [Abstract][Full Text] [Related]
30. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
31. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
Liu YA; Finn AJ; Subtil A
J Cutan Pathol; 2021 May; 48(5):617-624. PubMed ID: 33415780
[TBL] [Abstract][Full Text] [Related]
34. Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.
Del Guzzo CA; Kojadinovic A; Vinnakota RR; Geskin LJ; Newman JC; Langhoff E; Park YA; Bates SE; Dana AN
Oncologist; 2021 Sep; 26(9):727-e1488. PubMed ID: 33851477
[TBL] [Abstract][Full Text] [Related]
35. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
36. Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.
Marks E; Shi Y; Wang Y
Virchows Arch; 2019 Nov; 475(5):637-648. PubMed ID: 31218405
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
38. Mycosis fungoides in the pediatric population: report from an international Childhood Registry of Cutaneous Lymphoma.
Pope E; Weitzman S; Ngan B; Walsh S; Morel K; Williams J; Stein S; Garzon M; Knobler E; Lieber C; Turchan K; Wargon O; Tsuchiya A
J Cutan Med Surg; 2010; 14(1):1-6. PubMed ID: 20128983
[TBL] [Abstract][Full Text] [Related]
39. Risk of second malignancy after cutaneous T-cell lymphoma.
Kantor AF; Curtis RE; Vonderheid EC; van Scott EJ; Fraumeni JF
Cancer; 1989 Apr; 63(8):1612-5. PubMed ID: 2924268
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous γδ T-cell lymphoma following mycosis fungoides.
Suga H; Sugaya M; Miyagaki T; Ohmatsu H; Fujita H; Sato S
Int J Dermatol; 2014 Feb; 53(2):e82-4. PubMed ID: 24444029
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]